A detailed history of Sunbelt Securities, Inc. transactions in Novo Cure LTD stock. As of the latest transaction made, Sunbelt Securities, Inc. holds 4 shares of NVCR stock, worth $58. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4
Previous 7 42.86%
Holding current value
$58
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

SELL
$11.83 - $24.05 $35 - $72
-3 Reduced 42.86%
4 $0
Q4 2023

Feb 14, 2024

SELL
$11.13 - $15.78 $255 - $362
-23 Reduced 76.67%
7 $0
Q2 2023

Aug 15, 2023

SELL
$40.29 - $82.51 $684 - $1,402
-17 Reduced 36.17%
30 $1,000
Q1 2023

May 17, 2023

BUY
$56.44 - $118.81 $2,652 - $5,584
47 New
47 $2,000
Q4 2019

Feb 14, 2020

BUY
$68.3 - $93.8 $13,660 - $18,760
200 New
200 $4.21 Million

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $1.54B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Sunbelt Securities, Inc. Portfolio

Follow Sunbelt Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sunbelt Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sunbelt Securities, Inc. with notifications on news.